Selecta Biosciences, Inc.
Hedge Funds Holdings
Last updated:
Selecta Biosciences, Inc.‘s stocks are currently a part of 93 hedge funds’ portfolios, which represents 47.71% of the total amount of its stocks outstanding. This makes up a total of 54.55M shares of Selecta Biosciences, Inc.. Compared to the previous quarter, the number fell by -2.36% or -1.31M shares fewer. As for the holding position changes, 29.03% (27) of current hedge fund investors increased the number of shares held, 41.94% (39) of current holders sold a part of the shares held, and 20.43% (19) closed the holdings completely. 10 hedge funds are new holders of Selecta Biosciences, Inc. stock in Q1 2022, it is 10.75% of total holders.
Hedge funds holding Selecta Biosciences (Q2 2017 – Q1 2022)
| Q2 2017 | 47 |
|---|---|
| Q3 2017 | 53 |
| Q4 2017 | 62 |
| Q1 2018 | 58 |
| Q2 2018 | 57 |
| Q3 2018 | 65 |
| Q4 2018 | 54 |
| Q1 2019 | 54 |
| Q2 2019 | 42 |
| Q3 2019 | 35 |
| Q4 2019 | 38 |
| Q1 2020 | 59 |
| Q2 2020 | 80 |
| Q3 2020 | 77 |
| Q4 2020 | 92 |
| Q1 2021 | 94 |
| Q2 2021 | 97 |
| Q3 2021 | 99 |
| Q4 2021 | 103 |
| Q1 2022 | 93 |
Hedge funds changes in Selecta Biosciences positions (Q2 2017 – Q1 2022)
| Q2 2017 | 10 | 26 | 2 | 7 | 2 |
|---|---|---|---|---|---|
| Q3 2017 | 9 | 23 | 7 | 3 | 11 |
| Q4 2017 | 19 | 20 | 14 | 10 | -1 |
| Q1 2018 | 8 | 17 | 21 | 12 | 0 |
| Q2 2018 | 9 | 31 | 8 | 10 | -1 |
| Q3 2018 | 12 | 27 | 16 | 4 | 6 |
| Q4 2018 | 5 | 26 | 16 | 16 | -9 |
| Q1 2019 | 10 | 27 | 10 | 10 | -3 |
| Q2 2019 | 9 | 6 | 17 | 19 | -9 |
| Q3 2019 | 4 | 6 | 15 | 11 | -1 |
| Q4 2019 | 12 | 9 | 11 | 9 | -3 |
| Q1 2020 | 28 | 17 | 6 | 6 | 2 |
| Q2 2020 | 40 | 22 | 11 | 19 | -12 |
| Q3 2020 | 14 | 24 | 24 | 17 | -2 |
| Q4 2020 | 25 | 35 | 22 | 10 | 0 |
| Q1 2021 | 17 | 36 | 26 | 15 | 0 |
| Q2 2021 | 18 | 37 | 29 | 14 | -1 |
| Q3 2021 | 16 | 34 | 31 | 14 | 4 |
| Q4 2021 | 17 | 34 | 33 | 13 | 6 |
| Q1 2022 | 10 | 27 | 39 | 19 | -2 |
Hedge funds changes in Selecta Biosciences stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 0 | 0 |
|---|---|---|
| Q3 2017 | 0 | 0 |
| Q4 2017 | 0 | 0 |
| Q1 2018 | 0 | 2,000 |
| Q2 2018 | 44,000 | 7,000 |
| Q3 2018 | 1,440,000 | 0 |
| Q4 2018 | 1,000 | 10,000 |
| Q1 2019 | 9,000 | 30,000 |
| Q2 2019 | 5,000 | 9,000 |
| Q3 2019 | 53,000 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 70,000 | 1,000 |
| Q2 2020 | 183,000 | 79,000 |
| Q3 2020 | 361,000 | 97,000 |
| Q4 2020 | 353,000 | 564,000 |
| Q1 2021 | 5,254,000 | 1,355,000 |
| Q2 2021 | 2,888,000 | 635,000 |
| Q3 2021 | 2,731,000 | 329,000 |
| Q4 2021 | 815,000 | 98,000 |
| Q1 2022 | 188,000 | 45,000 |